HAVCR2 and neoplasm: Bladder cancer patients have high levels of TIM-3+ NK cells and Gal-9+ tumor cells, and patients with relatively low levels of TIM-3+ NK cells and Gal-9+ tumor cells have an improved prognosis (115).